肝活检后射频装置消融针道:单中心人体可行性研究
这项前瞻性单中心先导研究纳入10例肝占位且血小板计数和凝血酶原时间正常范围的患者,在超声引导下经皮肝活检后使用由绝缘鞘和射频施加器组成的装置消融活检针道。针道消融平均4.8秒,7例无疼痛、3例轻微疼痛,术中无不良事件,多普勒超声未见针道出血,CT未检出腹腔异常积液,电话随访未报告操作相关并发症,结论为技术可行。
要点
- 肝活检后使用射频装置消融针道,10例中7例无疼痛、3例轻微疼痛,术中无不良事件。
- 消融后即刻多普勒超声未见针道出血,次日平扫腹盆腔CT未检出腹腔异常积液。
- 活检后7天电话随访未报告操作相关并发症,作者认为该技术可行。
核心结论
- 使用该装置进行活检针道消融在技术上是可行的;若充分考虑其潜在优势并恰当使用,可能有助于降低肝活检相关并发症风险。
研究设计与样本
- 前瞻性单中心先导研究,经机构审查委员会批准并获书面知情同意,2015年9月至2016年3月纳入10例肝占位患者(男6例、女4例,35-66岁),血小板计数和凝血酶原时间均在正常范围,行经皮超声引导活检后以由绝缘鞘和射频施加器组成的装置消融针道。
临床应用与阅片要点
- 作者认为,若充分考虑该装置的潜在优势并恰当使用,可能有助于降低肝活检相关并发症风险。
- 原文未据此给出具体的临床操作推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The need for liver biopsy has been increasing because genetic testing of specimens has become important for determining prognosis and management in patients with hepatic malignancy. We evaluated the feasibility of a device for biopsy tract ablation in patients with hepatic masses.
METHODS: This prospective single-center pilot study was approved by our institutional review board and patients provided written informed consent. Between September 2015 and March 2016, 10 patients (6 males and 4 females, 35-66-years-old) who had hepatic masses and normal range of platelet count and prothrombin time were enrolled. After percutaneous ultrasound-guided biopsy, the biopsy tract was ablated with the device which consists of an insulation sheath and a radiofrequency applicator. Complications were evaluated with Doppler ultrasound immediately after the biopsy, with noncontrast abdominopelvic CT the day after the biopsy, and with a telephone interview 7 days after the biopsy.
RESULTS: Tract ablation did not cause any pain in seven patients and caused minimal pain in three3 patients. Tract ablation was performed for a mean of 4.8 s (range, 4-6 s). No adverse events occurred during the procedure. Bleeding through the biopsy tract was not apparent on Doppler ultrasound, and abnormal fluid was not detected in the abdominal cavity on CT. Procedure-related complications were not reported on telephone interview.
CONCLUSION: Biopsy tract ablation with the device is technically feasible. If the device is used appropriately considering its potential advantages, it may help to reduce the risk of complications associated with liver biopsy. Advances in knowledge: It is technically feasible to perform biopsy tract ablation with the radiofrequency ablation device after liver biopsy.
引用
- Song KD, Rhim H, Lee MW, et al. A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study. Br J Radiol. 2018. PMID: 29356562. doi:10.1259/bjr.20170585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。